Sangamo Therapeutics Stock Price on November 19, 2024
| SGMO Stock | USD 2.56 0.07 2.66% |
Below is the normalized historical share price chart for Sangamo Therapeutics extending back to April 06, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sangamo Therapeutics stands at 2.56, as last reported on the 30th of December, with the highest price reaching 2.73 and the lowest price hitting 2.53 during the day.
If you're considering investing in Sangamo Stock, it is important to understand the factors that can impact its price. Sangamo Therapeutics is dangerous given 3 months investment horizon. Sangamo Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.22, which indicates the firm had a 0.22% return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.26% are justified by taking the suggested risk. Use Sangamo Therapeutics Risk Adjusted Performance of 0.1769, semi deviation of 5.3, and Coefficient Of Variation of 475.28 to evaluate company specific risk that cannot be diversified away.
At this time, Sangamo Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 30th of December 2024, Common Stock Shares Outstanding is likely to grow to about 183.2 M, while Common Stock Total Equity is likely to drop about 1.4 M. . As of the 30th of December 2024, Price To Sales Ratio is likely to drop to 0.51. In addition to that, Price Earnings Ratio is likely to drop to -0.39. Sangamo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of April 2000 | 200 Day MA 0.819 | 50 Day MA 1.2712 | Beta 1.098 |
Sangamo |
Sharpe Ratio = 0.2218
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | SGMO | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.17 actual daily | 90 90% of assets are less volatile |
Expected Return
| 2.26 actual daily | 45 55% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Sangamo Therapeutics is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sangamo Therapeutics by adding it to a well-diversified portfolio.
Price Book 13.6489 | Enterprise Value Ebitda (1.00) | Price Sales 10.2147 | Shares Float 189.6 M | Wall Street Target Price 4.8 |
Related Headline
Intellia Therapeutics Headline on 19th of November 2024
Intellia Therapeutics Given New 70.00 Price Target at Wells ... by thelincolnianonline.com
Intellia Therapeutics had its price objective lowered by Wells Fargo Company from 80.00 to 70.00 in a report released on Monday morning,Benzinga reports. Wells Fargo Company currently has an overweight rating on the stock. A number of other equities research analysts have also issued reports on the stock. Robert
Sangamo Therapeutics Valuation on November 19, 2024
It is possible to determine the worth of Sangamo Therapeutics on a given historical date. On November 19, 2024 Sangamo was worth 1.88 at the beginning of the trading date compared to the closed value of 1.96. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sangamo Therapeutics stock. Still, in general, we apply an absolute valuation method to find Sangamo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sangamo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sangamo Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.07 | 2.17 | 1.82 | 1.90 | 6,611,344 | |
11/19/2024 | 1.88 | 2.03 | 1.85 | 1.96 | 6,356,169 |
| 2.06 | 2.11 | 1.89 | 1.95 | 6,701,599 |
| Backtest Sangamo Therapeutics | | | Sangamo Therapeutics History | | | Sangamo Therapeutics Valuation | Previous | Next |
Sangamo Therapeutics Trading Date Momentum on November 19, 2024
| On November 20 2024 Sangamo Therapeutics was traded for 1.95 at the closing time. The top price for the day was 2.11 and the lowest listed price was 1.89 . The trading volume for the day was 6.7 M. The trading history from November 20, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.51% . The trading price change against the current closing price is 17.35% . |
Sangamo Therapeutics Fundamentals Correlations and Trends
By evaluating Sangamo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sangamo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sangamo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sangamo Therapeutics Stock history
Sangamo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sangamo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sangamo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sangamo Therapeutics stock prices may prove useful in developing a viable investing in Sangamo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 174.4 M | 183.2 M | |
| Net Loss | -173.1 M | -164.4 M |
Sangamo Therapeutics Quarterly Net Working Capital |
|
Sangamo Therapeutics Stock Technical Analysis
Sangamo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sangamo Therapeutics Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Sangamo Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sangamo Therapeutics December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Sangamo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sangamo Therapeutics shares will generate the highest return on investment. By undertsting and applying Sangamo Therapeutics stock market strength indicators, traders can identify Sangamo Therapeutics entry and exit signals to maximize returns
Sangamo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sangamo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Sangamo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sangamo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1769 | |||
| Jensen Alpha | 2.11 | |||
| Total Risk Alpha | 1.83 | |||
| Sortino Ratio | 0.3265 | |||
| Treynor Ratio | (44.31) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sangamo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.24) | Revenue Per Share 0.066 | Quarterly Revenue Growth (0.95) | Return On Assets (0.58) | Return On Equity (1.94) |
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.